Viewing Study NCT05417308


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-03-08 @ 1:50 AM
Study NCT ID: NCT05417308
Status: RECRUITING
Last Update Posted: 2025-04-04
First Post: 2021-03-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
Sponsor: Ohio State University Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage I Breast Cancer AJCC v8 View
None Anatomic Stage IA Breast Cancer AJCC v8 View
None Anatomic Stage IB Breast Cancer AJCC v8 View
None Anatomic Stage II Breast Cancer AJCC v8 View
None Anatomic Stage IIA Breast Cancer AJCC v8 View
None Anatomic Stage IIB Breast Cancer AJCC v8 View
None Anatomic Stage III Breast Cancer AJCC v8 View
None Anatomic Stage IIIA Breast Cancer AJCC v8 View
None Anatomic Stage IIIB Breast Cancer AJCC v8 View
None Anatomic Stage IIIC Breast Cancer AJCC v8 View
None Anatomic Stage IV Breast Cancer AJCC v8 View
None Endocrine Therapy-Induced Alopecia View
None Prognostic Stage I Breast Cancer AJCC v8 View
None Prognostic Stage IA Breast Cancer AJCC v8 View
None Prognostic Stage IB Breast Cancer AJCC v8 View
None Prognostic Stage II Breast Cancer AJCC v8 View
None Prognostic Stage IIA Breast Cancer AJCC v8 View
None Prognostic Stage IIB Breast Cancer AJCC v8 View
None Prognostic Stage III Breast Cancer AJCC v8 View
None Prognostic Stage IIIA Breast Cancer AJCC v8 View
None Prognostic Stage IIIB Breast Cancer AJCC v8 View
None Prognostic Stage IIIC Breast Cancer AJCC v8 View
None Prognostic Stage IV Breast Cancer AJCC v8 View
Keywords: